Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: considerations regarding acquired heteroresistance and choice of carbapenemase detection assay-Reference-Cited by-同舟云学术

Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: considerations regarding acquired heteroresistance and choice of carbapenemase detection assay

Published:2020-07-17 Issue:10 Volume:75 Page:3075-3076
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Bianco Gabriele¹,Boattini Matteo¹,Iannaccone Marco¹,Cavallo Rossana¹,Costa Cristina¹

Affiliation:

1. Microbiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, Turin, Italy

Funder

internal funding

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/75/10/3075/33885400/dkaa283.pdf

Reference10 articles.

1. Resistance to ceftazidime-avibactam and underlying mechanisms;Wang;J Glob Antimicrob Resist,2019

2. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections;Shields;Antimicrob Agents Chemother,2017

3. Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum β-lactamases;Haidar;Antimicrob Agents Chemother,2017

4. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam;Galani;Clin Microbiol Infect,2019

5. In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment;Gaibani;J Antimicrob Chemother,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: bla _KPC-80 , bla _KPC-81 , bla _KPC-96 and bla _KPC-97;Microbiology Spectrum;2024-02-06

2. Klebsiella pneumoniae carbapenemase variant 44 acquires ceftazidime-avibactam resistance by altering the conformation of active-site loops;Journal of Biological Chemistry;2024-01

3. Klebsiella pneumoniae carbapenemase variants: the new threat to global public health;Clinical Microbiology Reviews;2023-12-20

4. Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018–2022);European Journal of Clinical Microbiology & Infectious Diseases;2023-11-21

5. Mobilization of the blaKPC-14 gene among heterogenous plasmids in extensively drug-resistant hypervirulent Klebsiella pneumoniae;Frontiers in Microbiology;2023-11-15